Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person drug-induced hearing loss

Class:IdDisease:9687683
_displayNamedrug-induced hearing loss
_timestamp2020-05-12 09:27:30
created[InstanceEdit:9687685] Stephan, Ralf, 2020-05-12
definitionA nonsyndromic deafness that is characterized by cochlear or vestibular dysfunction resulting in loss of hearing caused by drug ototoxicity.
identifier0070310
modified[InstanceEdit:9687759] Stephan, Ralf, 2020-05-12
namedrug-induced hearing loss
referenceDatabase[ReferenceDatabase:1247631] DOID
synonymdrug induced hearing loss
(disease)[ChemicalDrug:9687650] CHIR-99021 [cytosol]
[ChemicalDrug:9687651] AZD2858 [cytosol]
[ChemicalDrug:9687653] GSK-3beta inhibitor I [cytosol]
[ChemicalDrug:9687654] kenpaullone [cytosol]
[ChemicalDrug:9687660] AZD1080 [cytosol]
[ChemicalDrug:9687662] SB 216763 [cytosol]
[ChemicalDrug:9687664] alsterpaullone 2-cyanoethyl [cytosol]
[ChemicalDrug:9687667] GSK-3beta inhibitor VIII [cytosol]
[ChemicalDrug:9687668] GSK-3 inhibitor XIII [cytosol]
[ChemicalDrug:9687669] LY2090314 [cytosol]
List all 20 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by drug-induced hearing loss (9687683)